Home › Funds › Vitruvian Partners LLP › MXCT

Vitruvian Partners LLP position in MXCT

MAXCYTE INC · Health Care

Vitruvian Partners LLP reported holding 5,043,356 shares of MXCT (MAXCYTE INC) in its Q3 2026 13F filing — a position valued at US$5.6M, representing 4.99% of its reported portfolio and ranking #6 among its reported holdings. Vitruvian Partners LLP has disclosed MXCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)5.04M sh
Reported value held$5.65M
Portfolio Weight4.99%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vitruvian Partners LLP's MXCT position evolved

Vitruvian Partners LLP first disclosed a stake in MXCT in Q3 2023 at 5,043,356 shares (US$15.7M). The position peaked in Q4 2023 at 5,043,356 shares, worth US$23.7M. Across 13 filings, Vitruvian Partners LLP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 5,043,356 shares valued at US$5.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.04M $15.74M New
Q4 2023 5.04M $23.70M Hold
Q1 2024 5.04M $21.13M Hold
Q2 2024 5.04M $19.77M Hold
Q3 2024 5.04M $19.62M Hold
Q4 2024 5.04M $20.98M Hold
Q1 2025 5.04M $13.77M Hold
Q2 2025 5.04M $10.99M Hold
Q3 2025 5.04M $7.97M Hold
Q4 2025 5.04M $7.82M Hold
Q1 2026 5.04M $3.54M Hold
Q2 2026 5.04M $6.20M Hold
Q3 2026 5.04M $5.65M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MXCT and 13F data

MXCT (MAXCYTE INC) is a Health Care company. 22 other funds we track also report a position in MXCT — the largest reported positions include Capricorn Fund Managers Ltd (US$9.2M), Mudita Advisors LLP (US$4.1M), CADIAN CAPITAL MANAGEMENT, LP (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MXCT

All MXCT fund holders →

FAQ

How long has Vitruvian Partners LLP held MXCT?

Vitruvian Partners LLP has disclosed MXCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Vitruvian Partners LLP's current position in MXCT?

As of Q3 2026, Vitruvian Partners LLP holds 5.04M shares of MXCT (MAXCYTE INC), valued at $5.65M, representing 4.99% of its reported portfolio and ranking #6.

Has Vitruvian Partners LLP been buying or selling MXCT?

In the latest 13F filing (Q3 2026), Vitruvian Partners LLP held unchanged its position in MXCT. The position peaked in Q4 2023 at 5.04M shares.

Which other funds hold MXCT?

Other major institutional holders of MXCT include Capricorn Fund Managers Ltd, Mudita Advisors LLP, CADIAN CAPITAL MANAGEMENT, LP, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.